policy
Unapproved new animal drugs marketed as devices
The AVMA encourages increased enforcement in regulating the marketing of products represented as devices but appearing to be unapproved new animal…
JAVMA news
FTC pushes for more competition in pet medications market
The Federal Trade Commission released a report in May finding that veterinarians will continue to face increasing competition from nonveterinary…
JAVMA news
Company takes canine cancer drug off market to study dosing
Oasmia Pharmaceutical AB has taken a canine cancer drug, Paccal Vet, or paclitaxel for injection, off the market to study lowering the
JAVMA news
The slow rise of generic animal drugs
In human medicine, generic drugs accounted for 88 percent of prescriptions dispensed in the United States as of 2014.
JAVMA news
AVMA advocates against prescription mandate bill
In April, AVMA Board of Directors chair Dr. John de Jong testified before a House subcommittee about the Fairness to Pet Owners Act (HR 3174/S 1200),
JAVMA news
Assessing pet supplements
A third of all U.S. households with dogs use supplements, as do about a fifth of households with cats, according to a report on pet supplements from…
JAVMA news
DEA provides update on opioid shortage
The Drug Enforcement Administration released a statement April 10 on the ongoing opioid shortages affecting both human and veterinary medicine.
AVMA news
Canine osteoarthritis drug, Lyme disease bacteria vaccine receive approvals
Two recent drug approvals mean a novel treatment for the control of canine osteoarthritis (OA) pain and an oral vaccine against the wildlife spread of…
JAVMA news
More opioids available to veterinarians during ongoing shortage
The Food and Drug Administration announced Dec. 13 that the agency has worked with Pfizer Inc. to help alleviate a shortage of certain injectable…
JAVMA news
Banned in one name, allowed under another
A supplement maker accused of selling an unapproved kidney disease drug for pets is allowed to continue selling the product
JAVMA news
FDA identifies causes of drug shortages, proposes solutions
Logistical and regulatory challenges among cited issues
JAVMA news
FDA warns companies illegally selling CBD products
Agency signaled that it cannot conclude cannabidiol is safe.
policy
Notification to the veterinarian of violative residues in foods of animal origin
Veterinarians have an essential role in preventing such violations and ensuring the appropriate and judicious use of pharmaceuticals on food animal…
policy
Withdrawal of FDA approval for animal drug products
Loss of an animal drug product can have adverse effects on animal health, animal welfare and food safety.
JAVMA news
Supplement companies made changes after facing crackdown
The availability of glucosamine for animals seemed to be in question 15 years ago.
JAVMA news
Ruling could let drug sellers say more
A pharmaceutical salesman’s statements about off-label prescription drug uses were protected under the First Amendment, according to an appellate…
JAVMA news
New law supports FDA approval of more animal drugs
A new federal law includes language to expand conditional approval of animal drugs beyond minor uses and minor species,
JAVMA news
FDA offers aid toward antiparasitic drug approvals
The U.S. needs more drugs to fight parasites of sheep and goats, and the Food and Drug Administration promises to help companies get such drugs…
JAVMA news
The hype and hope of veterinary cannabis
A range of issues were covered at the first AVMA Cannabis Symposium, from regulatory and toxicological concerns to the drug’s potential as a…
JAVMA news
Generic drugs, skyrocketing prices
Over the years, generic prescription drugs approved for use in humans have provided tremendous savings in human and veterinary medicine alike.
Over-the-counter antimicrobials changing to prescription-only
The FDA has outlined its process for changing certain medically important antimicrobial drugs from over-the-counter (OTC) to prescription (Rx). Rx…
JAVMA news
FDA finalizes guidance on cell-based products in animals
The Food and Drug Administration issued final guidance June 11 on the agency’s current thinking about how existing regulations apply
policy
Adverse event reporting
The AVMA encourages veterinarians to report adverse events, and encourages continued development and strengthening of adverse event reporting systems.
JAVMA news
FDA issues guidance on regulation of cell-based products in animals
The Food and Drug Administration has issued draft guidance on the agency’s current thinking about how existing regulations apply to the use of…